A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96

Author： Bailey H.H.   Levy D.   Harris L.S.   Schink J.C.   Foss F.   Beatty P.   Wadler S.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.85, Iss.3, 2002-06, pp. : 464-468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of Ifosfamide+Doxorubicin in patients with advanced synovial sarcomas (E1793): a trial of the Eastern Cooperative Oncology Group

By Edmonson John H.   Ryan Louise M.   Falkson Carla I.   Hicks David G.   Blum Ronald H.  

Sarcoma, Vol. 7, Iss. 1, 2003-01 ,pp. : 9-11

Informa Healthcare

Access to resources Recommend Favorite

A Pilot Phase II Trial of Valspodar Modulation of Multidrug Resistance to Paclitaxel in the Treatment of Metastatic Carcinoma of the Breast (E1195): A Trial of the Eastern Cooperative Oncology Group

By Carlson Robert W.   O'Neill Anne M.   Goldstein Lori J.   Sikic Branimir I.   Abramson Neil   Stewart James A.   Davidson Nancy E.   Wood William C.  

Cancer Investigation, Vol. 24, Iss. 7, 2006-09 ,pp. : 677-681

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer

By Meadows Sherry   Mulkerin Daniel   Berlin Jordan   Bailey Howard   Kolesar Jill   Warren Deb   Thomas James  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 2-3, 2002-12 ,pp. : 125-128

Humana Press, Inc

Access to resources Recommend Favorite

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

By Lhomme C.   Vermorken J.B.   Mickiewicz E.   Chevalier B.   Alvarez A.   Mendiola C.   Pawinski A.   Lentz M.A.   Pecorelli S.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 194-199

Elsevier

Access to resources Recommend Favorite

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

By Aapro M.S.   van Wijk F.H.   van der Burg M.E.L.   ten Bokkel Huinink W.   Vergote I.   Guastalla J.P.   Rosso R.   Kobierska A.   Beex L.V.A.   Namer M.   Splinter T.E.W.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1141-1143

Elsevier

Access to resources Recommend Favorite